Trodelvy injection Price in India

Trodelvy (sacituzumab govitecan) is an antibody-drug conjugate indicated for certain patients with HR+/HER2- metastatic breast cancer (mBC) and triple-negative breast cancer (TNBC). The Trodelvy price in India is not established as the drug is not approved in India by the CDSCO. Indian patients can access Trodelvy through legal import mechanisms. Under these provisions—used especially for unapproved or unavailable life-saving medicines—patients or treating physicians may request Trodelvy under their name (Named Patient Program), using a valid medical prescription and applicable import permits (Form 12A/12B). Indian Pharma Network (IPN) assists in importing this medicine and navigating complex regulatory pathways. We coordinate documentation, import permissions, and logistics to help hospitals, doctors, and patients legally obtain Trodelvy from trusted international sources—ensuring compliance with all relevant regulations. Kindly call/WhatsApp: + 91-9310090915 to know more.